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We investigate the relationship between the blood flow velocities (BFV) in the middle cerebral
arteries and beat-to-beat blood pressure (BP) recorded from a finger in healthy and post-stroke
subjects during the quasi-steady state after perturbation for four different physiologic conditions:
supine rest, head-up tilt, hyperventilation and CO2 rebreathing in upright position. To evaluate
whether instantaneous BP changes in the steady state are coupled with instantaneous changes in the
BFV, we compare dynamical patterns in the instantaneous phases of these signals, obtained from
the Hilbert transform, as a function of time. We find that in post-stroke subjects the instantaneous
phase increments of BP and BFV exhibit well pronounced patterns that remain stable in time for all
four physiologic conditions, while in healthy subjects these patterns are different, less pronounced
and more variable. We propose a new approach based on the cross-correlation of the instantaneous
phase increments to quantify the coupling between BP and BFV signals. We find that the maximum
correlation strength is different for the two groups and for the different conditions. For healthy
subjects the amplitude of the cross-correlation between the instantaneous phase increments of BP
and BFV is small and attenuates within 3-5 heartbeats. In contrast, for post-stroke subjects, this
amplitude is significantly larger and cross-correlations persist up to 20 heartbeats. Further, we
show that the instantaneous phase increments of BP and BFV are cross-correlated even within a
single heartbeat cycle. We compare the results of our approach with three complementary methods:
direct BP-BFV cross-correlation, transfer function analysis and phase synchronization analysis. Our
findings provide new insight into the mechanism of cerebral vascular control in healthy subjects,
suggesting that this control mechanism may involve rapid adjustments (within a heartbeat) of the
cerebral vessels, so that BFV remains steady in response to changes in peripheral BP.
PACS numbers: 05.40.-a,87.19.Hh,87.10.+e
I. INTRODUCTION
Cerebral autoregulation (CA) is the ability of cerebral
blood vessels to maintain steady cerebral perfusion in re-
sponse to fluctuations of systemic blood pressure (BP),
postural changes or metabolic demands. This regula-
tory mechanism is known to operate over a range of
blood pressure values (e.g. 80 - 150 mm Hg) [1] and
on time scales of a few heartbeats [2]. The long-term
CA compensates for chronic BP elevations and metabolic
demands [3]. Ischemic stroke is associated with an im-
pairment of autoregulation [4, 5], that may permanently
affect cerebrovascular reactivity to chemical and blood
pressure stimuli [6, 7]. With impaired CA, the cerebral
blood flow follows BP fluctuations, posing a risk of in-
sufficient blood supply to the brain during transient re-
ductions in peripheral BP. Therefore, evaluating the ef-
fectiveness of CA is of great interest, given the clinical
implications.
∗VN and PChI contributed equally to this work. VN designed
the clinical study, provided data and guidance of the physiological
aspects. PChI proposed the instantaneous phase cross-correlation
method, and guided the computational aspects.
Traditional experimental methods evaluating the
mechanism of CA require time-consuming invasive proce-
dures [8, 9] and are focused on long term BP and blood
flow velocities (BFV) characteristics such as the mean,
lacking descriptors of temporal BP-BFV relationship. To
address this problem, an alternative “dynamic” approach
has been proposed [10] to quantify CA using transcra-
nial Doppler ultrasound during the transient responses
in cerebral BFV to the rapid BP changes induced ex-
perimentally by thigh cuff inflation, Valsalva maneuver,
tilt-up, or a change in posture [3, 11]. The autoregulation
indices derived from this approach may be more sensitive
to indicators of hypoperfusion after stroke [12].
The analytic methods evaluating the dynamics of cere-
bral autoregulation are currently based on mathemati-
cal modeling and Fourier transform analysis [13]. The
Fourier transform based transfer function method has
been widely used [2]. This method estimates the rela-
tive cross-spectrum between BP and BFV signals in the
frequency domain. Dynamic indices of autoregulation,
based on Fourier transform methods, presume (i) signal
stationarity (i.e., the mean and standard deviation of the
signal are stable and remain invariant under a time shift)
and (ii) a linear BP-BFV relationship. However, physio-
logic signals are often nonstationary reflecting transient
responses to physiologic stimuli [14]. The effect of this
2nonstationarity on the results obtained from the trans-
fer function analysis has not been carefully assessed in
previous studies.
Here we investigate the dynamics of the BP-BFV rela-
tionship when the system reaches the quasi-steady state
after an initial perturbation. While studies traditionally
have focused on the response in BFV to transient changes
in BP [3], we hypothesize that spontaneous physiologic
fluctuations during the quasi-steady state, which is char-
acterized by absence of physiologic stimuli or constant
level of stimulation, may also contain important infor-
mation about the CA mechanism.
Our focus on fluctuations in the BP and BFV is mo-
tivated by previous work which has demonstrated that
physiologic fluctuations contain important information
about the underlying mechanisms of physiologic control.
Robust temporal organization was reported for the fluc-
tuations characterizing cardiac dynamics (inter-beat in-
tervals) [15, 16, 17, 18, 19, 20, 21, 22], respiratory dy-
namics (inter-breath intervals) [23, 24, 25, 26, 27], loco-
motion (gait, fore-arm motion) [28, 29, 30, 31, 32, 33],
and brain dynamics [34, 35, 36]. Moreover, it has been
demonstrated that physiologic fluctuations carry infor-
mation reflecting the coupling between different physio-
logic systems, e.g., correlations in the heartbeat change
with physical activity [37, 38], with wake and sleep [39],
during different sleep stages [40, 41, 42, 43], and even
different circadian phases [44]. BP and BFV signals are
impacted by the heartbeat, and thus one can expect that
fluctuations in BP and BFV may reflect modulation in
the underlying mechanisms of control. Previous stud-
ies have focused on the transitional changes in BP and
BFV in response to abrupt perturbation of the physio-
logic state, e.g., rapid switch from supine to tilt. In con-
trast, we focus on the dynamical characteristics of BP
and BFV signals after the initial perturbation, when the
system has reached a quasi-steady state during which
there is no change in physiologic stimuli. Further, we
hypothesize that certain dynamical characteristics of the
fluctuations in BP and BFV at the steady state, and how
these characteristics change for different physiologic con-
ditions, may reflect aspects of the underlying mechanism
of CA. For example, under normal CA the fluctuations
of the BFV in healthy subjects at the steady state may
relate to high frequency adjustments (even within a sin-
gle heartbeat) of the diameter of the cerebral blood ves-
sels, while loss of CA after stroke may lead to impaired
vascular dilation or contraction associated with reduced
fluctuations in BFV.
To test this hypothesis, we measure BP and BFV sig-
nals from healthy and post-stroke subjects during four
physiologic conditions: supine, tilt, hyperventilation, and
CO2 rebreathing in upright position. We apply several
complementary methods to quantify the dynamical BP-
BFV relationship in these quasi-steady conditions: trans-
fer function analysis, cross-correlation and phase syn-
chronization analyses, and we compare these methods
with a new approach of cross-correlation between the in-
stantaneous phase increments of BP and BFV signals.
Interactions between peripheral circulation (beat-to-beat
BP) and cerebral vasoregulation [BFV in the middle cere-
bral artery (MCA)] can be modeled as dynamic synchro-
nization of two coupled nonlinear systems. Specifically,
We hypothesize that the CA mechanism may also involve
adjustments in the cerebral vascular tone to spontaneous
changes in BP that may be present within a single heart-
beat even when the system is in the steady state and
there are no significant changes in the mean blood pres-
sure.
The synchronization phenomenon was first observed
by Hugenii for two coupled pendulum clocks [45], and
since then it has been found in many physical and bio-
logical systems where two or more coupled subsystems
interact [46, 47, 48, 49, 50, 51, 52]. Alternatively, the
synchronization may also be triggered by the influence
of external noisy or regular fields [53, 54]. In recent
years, the concept of synchronization has been widely
used to study the coupling of oscillating systems, leading
to the discovery of phase synchronization in non-identical
coupled systems in which the instantaneous phases are
synchronized, while their instantaneous amplitudes re-
main uncorrelated [55, 56, 57, 58]. Such phase syn-
chronization has been empirically discovered in a range
of physical and physiological systems [59, 60]. Specifi-
cally, studies have found coupling between the cardiac
rhythm and other systems: phase synchronization was
observed between the heartbeat and respiration during
normal conditions [61] and during respiratory sinus ar-
rhythmia [62, 63], change of cardiorespiratory phase syn-
chronization with new-borns’ age [64] and with the level
of anaesthesia [65]. Phase analysis methods have been
used to probe spatial synchronization of oscillations in
blood distribution systems [66], between cortical centers
during migraine [67], as well as between certain brain
areas and muscle activity of the limbs [68].
In this study we evaluate the time-domain characteris-
tics of both the amplitudes and the instantaneous phases
of the BP and BFV which can be considered as two in-
teracting subsystems within the CA mechanism. To de-
termine the characteristics of the coupling between BP
and BFV in healthy subjects and how they change with
stroke, we analyze the cross-correlation between the in-
stantaneous phase increments of these two signals. We
find that this cross-correlation is much stronger for post-
stroke subjects, indicating increased synchronization be-
tween BP and BFV, which suggests impaired mechanism
of the CA. We compare the results of the instantaneous
phase increment cross-correlation analysis with those ob-
tained from several complementary methods including
the transfer function, cross-correlation and phase syn-
chronization analyses.
3Variable Demographic characteristics
Control Stroke
Men/Women 4/7 7/6
Age(mean±SD) 48.2 ± 8.7 52.8± 7.1
Race W/AA 10/1 12/1
Stroke side – 5/8
(Right/Left)
Group Supine Tilt Hyperventilation CO2 rebreathing Statistics
(mean±SD) Control Stroke Control Stroke Control Stroke Control Stroke (P values)
BP (mm Hg) 96.4± 20.9 101.0± 20.6 93.1± 20.1 105.9 ± 22.5 94.2± 19.7 105.4± 22.0 97.6± 21.7 108.8± 22.7 0.66∗ 0.0005†
BFV-MCAR/ 66.0± 18.7 55.2 ± 18.0 57.3± 18.1 49.7± 18.5 40.3± 15.7 39.8± 14.9 54.7± 21.9 56.3 ± 21.5 < 0.0001∗ 0.77†
Normal side(cm/s)
BFV-MCAL/ 63.5± 19.6 51.1 ± 19.0 54.8± 17.1 51.5± 19.3 40.8± 14.9 41.0± 17.9 54.6± 21.5 57.4 ± 23.3 < 0.0001∗ 0.008†
Stroke side(cm/s)
CO2(mm Hg) 33.5± 6.0 37.7± 4.9 32.0± 3.6 32.5 ± 2.5 21.0± 4.5 23.5± 8.0 34.6± 7.2 33.2± 6.5 < 0.0001
∗ 0.28†
CVR**-MCAR 1.54± 0.45 1.96 ± 0.54 1.75± 0.53 2.28± 0.93 2.68± 1.10 3.00± 1.28 1.97± 0.61 2.17 ± 0.83 0.0001∗ 0.007†
/Normal side
CVR-MCAL 1.59± 0.56 1.97 ± 0.65 1.79± 0.61 2.29± 0.83 2.57± 0.90 3.04± 1.60 1.96± 0.56 2.19 ± 0.94 0.0001∗ 0.01†
/Stroke side
* P value between physiologic conditions comparisons
† P value between groups comparisons
** CVR (cerebral vascular resistance) is defined as mean BP/BFV
TABLE I: Demographic characteristics.
II. METHODS
A. Study Groups
We obtain data from the Autonomic Nervous System
Laboratory at the Department of Neurology at The Ohio
State University and from the SAFE (Syncope and Falls
in the Elderly) Laboratory at the Beth Israel Deaconess
Medical Center at Harvard Medical School. All subjects
have signed informed consent, approved by the Institu-
tional Review Boards. Demographic characteristics are
summarized in Table I. Control group: 11 healthy sub-
jects (age 48.2 ± 8.7 years). Stroke group: 13 subjects
with a first minor ischemic stroke ( > 2 months after
acute onset) (age 52.8± 7.1 years). Post-stroke subjects
have a documented infarct affecting < 1/3 of the vascu-
lar territory as determined by MRI or CT with a minor
neurological deficit (Modified Rankin Score scale < 3).
The side of the lesion is determined by neurological eval-
uation and confirmed with MRI and CT. The lesion is in
the right hemisphere in 5 of the subjects and in the left
hemisphere in 8 of the subjects. Normal carotid Doppler
ultrasound study is required for participation. Patients
with hemorrhagic strokes, clinically important cardiac
disease including major arrhythmias, diabetes and any
other systemic illness are excluded. All subjects are care-
fully screened with a medical history, physical and labo-
ratory examination.
B. Experimental Protocol
All subjects have participated in the following experi-
mental protocol:
• Baseline supine rest — normal breathing (normocap-
nia): subject rests in supine position for 5 minutes on a
tilt table;
• Head-up tilt — upright normocapnia: The tilt table is
moved upright to an 80◦ angle. The subject remains in
upright position for 5 minutes and is breathing sponta-
neously;
• Hyperventilation — upright hypocapnia: the subject is
asked to breathe rapidly at ≈1 Hz frequency for 3 min-
utes in an upright position. Hyperventilation induces
hypocapnia (reduced carbon dioxide), which is associated
with cerebral vasoconstriction;
• CO2 rebreathing — upright hypercapnia: The subject
is asked to breath a mixture of air and 5% CO2 from
rebreathing circuit at a comfortable frequency for 3 min-
utes in an upright position. CO2 rebreathing increases
carbon dioxide above normal levels and induces hyper-
capnia, which is associated with vasodilatation.
The mechanism of CA is at least partially related to
the coupling between metabolic demands and oxygen
supply to the brain [3]. Carbon dioxide (CO2) is one
of the most potent chemical regulators of cerebral va-
soreactivity. Head-up tilt provides both pressure and
chemical stimulus — BFV and CO2 decline in upright
position, reflecting the change in intracranial pressure
and shifting autoregulatory curve towards lower BP val-
ues. There is a linear relationship between CO2 values
and cerebral blood flow: hypocapnia (through hyper-
ventilation) causes vasoconstriction and thus decreases
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FIG. 1: BP and BFV signals during CO2 re-breathing after a band-pass Fourier filter in the range [0.05Hz, 10Hz] and normal-
ization to unit standard deviation: (a-b) for a healthy subject, (c-d) for a post-stroke subject.
the blood flow, hypercapnia (through CO2 rebreathing)
causes vasodilatation and increases the blood flow in the
brain [3].
C. Data Acquisition
We perform experiments in the morning or more than
2 hours after the last meal. We measure the electrocar-
diogram from a modified standard lead II or III using
a SpaceLab Monitor (SpaceLab Medical Inc., Issaquah,
WA). We record beat-to-beat BP from a finger with a Fi-
napres device (Ohmeda Monitoring Systems, Englewood
CO), which is based on a photoplethysmographic vol-
ume clamp method. During the study protocol, we ver-
ify BP by arterial tonometry. With finger position at
the heart level and temperature kept constant, the Fi-
napres device can reliably track intraarterial BP changes
over prolonged periods of time. We measure the res-
piratory waveforms with a nasal thermistor. We mea-
sure CO2 from a mask using an infrared end tidal vol-
ume CO2 monitor (Datex Ohmeda, Madison WI). We
insonate the right and left MCAs from the temporal win-
dows, by placing the 2-MHz probe in the temporal area
above the zygomatic arch using a transcranial Doppler
ultrasonography system (MultiDop X4, DWL Neuroscan
Inc, Sterling, VA). Each probe is positioned to record
the maximal BFV and is fixed at a desired angle us-
ing a three-dimensional positioning system attached to
the light-metal probe holder. Special attention is given
to stabilizing the probes, since their steady position is
crucial for reliable, continuous BFV recordings. BFV
and all cardiovascular analog signals are continuously ac-
quired on a beat-to-beat basis and stored for off-line post-
processing. We visually inspect the data and remove oc-
casional extrasystoles and outlier data points using lin-
ear interpolation. We use the Fourier transform of the
Doppler shift (the difference between the frequency of the
emitted signal and the echo frequency of the reflected sig-
nal) to calculate BFV. BFVs in the MCA correlate with
invasive measurements of blood flow with xenon clear-
ance, laser Doppler flux and positron emission tomogra-
phy [69, 70, 71]. Since the MCA diameter is relatively
constant under physiological conditions [72], BFV can be
used for blood flow estimates.
D. Statistical Analyses
We use the multiple analysis of variance (MANOVA)
with 2x4 design for the two groups (control and stroke)
and for four physiologic conditions (supine, tilt, hy-
perventilation, and CO2 rebreathing) with subjects as
nested random effects (JMP version 5 Software Analysis
Package, SAS Institute, Cary, NC). For each group and
condition, we calculate: (i) the mean BP, BFV, cerebral
vascular resistance (CVR, calculated by mean BP/BFV)
from the right and the left MCAs, and CO2 (see Ta-
ble I); (ii) gain, phase and coherence from transfer func-
tion analysis (see Table II); and (iii) the direct cross-
correlation, the phase synchronization, and the cross-
correlation of instantaneous phase increments of BP and
BFV (see Table III). We analyze BFV on the stroke side
in the right MCA in 5 patients and in the left MCA in
8 patients. In our comparative tests, we consider the
side opposite to the stroke side as the “normal” side, as
we did not a priori know whether the side opposite to
the stroke side would exhibit normal or perturbed be-
havior. In the group comparison, we compare the stroke
side BFV for the stroke group to the BFV in the left side
MCA for the control group because the majority of post-
stroke subjects had stroke on their left side. We note
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FIG. 2: Cross-correlation function C(τ ) for the BP and BFV signals during four physiologic conditions: (a) for the same
healthy subject and (b) for the same post-stroke subject as shown in Fig. 1. BP and BFV signals are pre-processed using a
band-pass Fourier filter in the range [0.05Hz, 10Hz] and are normalized to unit standard deviation before the analysis. Since
BFV precedes BP, the maximum value Cmax in the cross-correlation function C(τ ) is located not at zero lag but at τ ≈ −0.1
sec.
that our comparative tests between the stroke side BFV
for post-stroke subjects and the right side BFV for the
control group show similar results. We compare the nor-
mal side (opposite to the stroke side) BFV for the stroke
group to the BFV in the right side MCA for the control
group.
Method 1: Transfer Function Analysis
We first normalize the BP and BFV signals to unit
standard deviation to obtain the respective signals P (t)
and V (t). We then calculate their respective Fourier
transforms V (f) and P (f). In the frequency domain,
the coherence function γ2(f) is defined as
γ2(f) ≡
|SPV (f)|
2
SPP (f)SV V (f)
, (1)
where SV V (f) = |V (f)|
2, SPP (f) = |P (f)|
2 and
SPV (f) = P
∗(f)V (f) are the power spectra of V (t),
P (t) and the cross-spectrum of V (t) and P (t), respec-
tively. The value of the coherence function γ2(f) varies
between 0 and 1. The transfer function H(f) is defined
as
H(f) ≡
SPV (f)
SPP (f)
. (2)
From the real part HR(f) and imaginary part HI(f) of
the transfer function, we can obtain its amplitude (also
called gain)
|H(f)| ≡ [H2R(f) +H
2
I (f)]
1/2, (3)
and its phase
Φ(f) ≡ arctan[HI(f)/HR(f)]. (4)
We note that the phase Φ(f) is a frequency domain char-
acteristic of the cross-spectrum between two signals, and
is different from the instantaneous phase in the time do-
main we discuss in Method 3 and Method 4.
Method 2: Cross-correlation Analysis
To test dynamical aspects of the mechanism of CA,
we investigate the cross-correlation between BP and
BFV signals and how this cross-correlation changes un-
der stroke. Although we consider segments of the BP
and BFV recordings during the quasi-steady state, where
we have constant level (or absence) of physiologic stim-
uli, these signals may still exhibit certain trends in the
mean value. So, to eliminate these trends, we first pre-
process the BP and BFV signals applying a band-pass
filter (10Hz > f > 0.05Hz) in the frequency domain. To
be able to compare signals with different amplitude, we
next normalize the band-passed signals to unit standard
deviation (Fig. 1). Finally, we perform a cross-correlation
analysis estimating the cross-correlation function C(τ)
for a broad range of values for the time lag τ , where
C(τ) is defined as:
C(τ) ≡
〈(P (t)− 〈P 〉)(V (t+ τ)− 〈V 〉)〉
σPσV
, (5)
and 〈...〉 and σ denote the mean and standard deviation
of a signal.
Results of our cross-correlation analysis for one healthy
subject and one post-stroke subject during all four phys-
iologic conditions are shown in Fig. 2 and are discussed
in Sec. III C.
Method 3: Phase Synchronization Analysis
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FIG. 3: (a) The relative phases ϕBFV (t) − ϕBP (t) for healthy subjects (a) and post-stroke subjects (b), where ϕ(t) is the
instantaneous phase of a signal. The phase difference of BFV and BP for both groups may fluctuate around a constant value
or jump between different constant values. The distributions of Ψ1,1 ≡ (2pi)
−1[ϕBFV (t)− ϕBP (t)] mod 1 for healthy subjects
and for post-stroke subjects are shown in (c) and (d), respectively. The number of bins in the histogram is N = 40.
We study beat-to-beat BP-BFV interaction during
quasi-steady state conditions (supine rest, upright tilt,
upright hyperventilation and CO2 rebreathing employing
a phase synchronization method. We first apply a high-
pass (f > 0.05Hz) and a low-pass (f < 10Hz) Fourier
filter to the BP and BFV signals. The high-pass filter is
used to reduce nonstationarity related to slow trends in
the mean of the signals. The low-pass filter is used to re-
move high frequency random fluctuations in the signals.
Next we perform the Hilbert transform which for a time
series s(t) is defined as [55, 56, 73, 74, 75, 76]
s˜(t) ≡
1
pi
P
∫ ∞
−∞
s(τ)
t− τ
dτ, (6)
where P denotes Cauchy principal value. s˜(t) has an
apparent physical meaning in Fourier space: for any pos-
itive (negative) frequency f , the Fourier component of
the Hilbert transform s˜(t) at this frequency f can be ob-
tained from the Fourier component of the original signal
s(t) at the same frequency f after a 90◦ clockwise (anti-
clockwise) rotation in the complex plane. For example,
if the original signal is sin(ωt), its Hilbert transform will
become cos(ωt). For any signal s(t) one can always con-
struct its “analytic signal” S [55, 56, 73, 74, 76], which
is defined as
S ≡ s(t) + is˜(t) = A(t)eiϕ(t), (7)
where A(t) and ϕ(t) are the instantaneous amplitude and
instantaneous phase of s(t), respectively. Application of
the analytic signal approach to heartbeat dynamics has
been shown in [15, 75]. The instantaneous amplitude
A(t) and the instantaneous phase ϕ(t) are instantaneous
characteristics of a time series s(t), and present different
aspects of the signal. For a pure sinusoid, A(t) is a con-
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FIG. 4: (a) The relative phases ϕBFV (t1)− ϕBP (t2) for a healthy subject and a post-stroke subject. We find that the relative
phases between BFV and BP depend on the time difference t2− t1 between these two signals. Accordingly, the distributions of
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also depend on the time difference between BFV and BP. We note that, our choice of time difference t2 − t1 = 0.4 sec is
arbitrary and does not carry any specific physiologic meaning. The number of bins in the histogram is N = 40.
stant and ϕ(t) increases linearly in time: the amplitude
quantifies the strength of the oscillation and the slope of
the straight line formed by the increasing phase quanti-
fies how fast is the oscillation. For more complex signals,
both A(t) and ϕ(t) may display complicated forms. Fur-
ther, we note that the instantaneous phase ϕ(t) is dif-
ferent from the transfer function phase Φ(f): ϕ(t) is a
time domain characteristic of a single signal, while Φ(f)
is a cross-spectrum characteristic of two signals in the
frequency domain.
From the definition of the Fourier transform one can
find that the mean of a given signal s(t) is proportional
to the Fourier component of s(t) at the frequency f = 0.
After applying the high-pass filter (f > 0.05 Hz), the
Fourier component of s(t) at f = 0 is filtered out, and
correspondingly, the mean of the filtered signal becomes
zero. Furthermore, from the definition of the Hilbert
transform, one can find that the Hilbert transforms of
two signals s(t) and s(t) + c (where c 6= 0 is a constant)
are identical, although the two original signals have ob-
viously different means due to the constant c. Since both
the instantaneous phase ϕ(t) and amplitude A(t) depend
on the original signal as well as on the Hilbert transform
of the original signal (see Eq. 7), the instantaneous phase
and amplitude for s(t) and s(t) + c will be also different.
However, when we let both signals s(t) and s(t) + c pass
a high-pass filter (f > 0.05 Hz), the mean of both signals
becomes zero, and both signals will have identical phases
and amplitudes. Thus, the phase and amplitude of a sig-
nal does not depend on its mean, and is uniquely defined
after the signal is processed with a high-pass filter.
Following [55] we estimate the difference between
the instantaneous phases of the BFV and BP signals
ϕBFV (t) − ϕBP (t) at the same time t. We then obtain
the probability density p for the quantity
Ψ1,1 ≡ (2pi)
−1[ϕBFV (t)− ϕBP (t)] mod 1, (8)
following the approach presented in [68]. To quantify the
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FIG. 5: Presentation of the BP and BFV signals vs. their Hilbert transforms (a-b) and their corresponding instantaneous phase
increment ∆ϕ during the CO2 re-breathing condition (c-d) for the same data from a healthy subject as shown in Fig. 1a-b. BP
and BFV signals vs. their Hilbert transforms (e-f) and their corresponding instantaneous phase increment ∆ϕ during the CO2
re-breathing condition (g-h) for the same data from a post-stroke subject as shown in Fig. 1c-d. Repetitive temporal patterns
associated with each heartbeat in ∆ϕ for the BP signal from a healthy subject (c) are not matched by corresponding patterns
in the BFV signal (d), reflecting active cerebral vascular regulation. In contrast, periodic patterns in ∆ϕ of the BP signal
from a post-stroke subject (g) are matched by practically identical patterns in ∆ϕ of the BFV signal (h), indicating dramatic
impairment of cerebral vascular tone with higher vascular resistance after minor ischemic stroke.
shape of the probability density p, which can be very
broad (uniform) for non-synchronized signals and very
narrow (peaked) for strongly synchronized signals, we
utilize the index ρ [68]. The index ρ is based on the
Shannon entropy and is defined as
ρ ≡ (Smax − S)/Smax, (9)
where S = −
∑N
k=1 pklnpk is the Shannon entropy of the
distribution of Ψ1,1 and Smax = lnN corresponds to the
uniform distribution, where N is the number of bins. In
our calculations, we choose N = 40. For the normalized
index ρ, we have 0 ≤ ρ ≤ 1, where ρ = 0 corresponds
to a uniform distribution (no synchronization) and ρ = 1
corresponds to a Dirac-like distribution (perfect synchro-
nization).
Results of our synchronization analysis for several
healthy and post-stroke subjects are shown in Figs. 3
and 4, and are discussed in Sec. III D.
Method 4: Cross-correlation of Instantaneous Phase In-
crements
The instantaneous phase ϕ(t) for both BP and BFV is
a nonstationary signal and can be decomposed into two
parts: a linear trend and fluctuations along the trend.
The trend is mainly driven by the periodic heart rate at
a frequency ≈ 1 Hz. However, the fluctuations are of spe-
cific interest, since they may be affected by the cerebral
9autoregulation. To remove the trend, we consider the in-
crements in the consecutive values of the instantaneous
phase, defined as
∆ϕ(ti) ≡ ϕ(ti)− ϕ(ti−1), (10)
where ti and ti−1 are the times corresponding to two
successive recordings (in our case we have ti − ti−1 =
0.02sec). The instantaneous phase increment signal ∆ϕ
is stationary in the sense that it has fixed mean and fixed
standard deviation, and fluctuates in the range (−pi, pi].
In Figs. 5(c), 5(d) we show examples of ∆ϕ for healthy
subjects and in Figs. 5(g), 5(h) for post-stroke subjects.
We then apply a cross-correlation analysis to quantify
the dynamical relationship between the stationary phase
increments ∆ϕ of the BP and BFV signals. For each sub-
ject, during each physiologic condition we calculate the
correlation coefficient C(τ) vs. the time lag τ between
the BP and BFV signals. To quantitatively distinguish
the control group and the stroke group, we further ana-
lyze the characteristics of the correlation function C(τ).
Specifically, we investigate the maximum value of C(τ),
denoted as Cmax, which represents the strength of the
cross-correlation between the instantaneous phases of the
BP and BFV signals. Another important characteristic
of the cross-correlation function is how fast the correla-
tion between two signals decreases for increasing values
of the time lag τ . To quantify this aspect, we choose a
fixed threshold value, r = 0.3, which is the same for all
subjects and for which we obtain a good separation be-
tween the control and the stroke group. Since C(τ) is a
periodic-like function of the time lag τ with a decreas-
ing amplitude for increasing τ (Fig. 6), we first record all
maxima of |C(τ)| during each heart beat period (∼1 sec),
then we determine the two maxima with largest positive
and negative time lags τ at which the correlation function
C(τ) is above rCmax. The average of the absolute values
for these two time lags is marked as a characteristic time
lag τ0.
In summary we note that, to avoid problems with the
nonstationarity when applying the cross-correlation anal-
ysis between instantaneous phase increments, we have
performed the following steps: (1) We have considered
BFV and BP at the steady state for all four physiologic
conditions, and we have analyzed only short segments
(≈ 2.3 minutes) of data during which the heart rate
remains approximately stable; (2) We have performed
cross-correlation analysis after pre-processing BFV and
BP signals by a high-pass filter, thus removing low fre-
quency trends; (3) The phase increment signals ∆ϕ are
stationary at least according to the definition of weak
stationarity. For the data segments we consider, ∆ϕ has
a constant mean value and fluctuates within a fixed range
(−pi,+pi].
III. RESULTS
A. Mean Values
We compare the mean values of all signals for
both control and stroke groups and for all four phys-
iologic conditions (baseline supine rest, upright tilt,
tilt-hyperventilation and CO2 rebreathing) using the
MANOVA method. Our results are shown in Table I.
We see that the mean values of the BFV and CO2 signals
are significantly different for the four different conditions
while the BP mean values are similar. For control and
stroke group comparison, we find that BFVs from the
left (stroke side) MCA were significantly different, and
that the mean value of BP for the stroke group is signif-
icantly higher than that for control group. Furthermore,
we observe that the cerebral vascular resistance (CVR)
is significantly higher for the stroke group.
B. Transfer Function Analysis
We apply transfer function analysis on the original BP
and BFV signals under different physiologic conditions in
both the low frequency (LF) (0.05-0.2 Hz) and the heart
beat frequency (HBF) (0.7-1.4 Hz) range. Gain, phase
and coherence are calculated for each subject and for all
four physiologic conditions (Table II). We use MANOVA
to compare our results for the two groups and for the four
conditions. In both frequency ranges, we do not find sig-
nificant difference in the gain. In the LF range, phase
Φ(f) and coherence γ2(f) are significantly different be-
tween the physiologic conditions, but are not different
between the groups. In the HBF range, we find that the
phase Φ(f) for the MCAL-BFV is significantly different
between the conditions (p=0.03). The coherence in the
HBF range shows no significant difference in the physi-
ologic conditions comparison, however, it is significantly
higher for the control group.
C. Cross-correlation Analysis
We have performed a cross-correlation analysis di-
rectly between the BP and BFV signals, after first pre-
processing these signals by a high-pass filter as shown in
Fig. 1. Representative examples for the cross-correlation
function over a broad range of time lags τ for one healthy
and one post-stroke subject during the four physiologic
conditions (supine, tilt, hyperventilation, CO2 rebreath-
ing) are shown in Fig. 2. Group statistics and compara-
tive tests are included in Table III.
The BFV data show more random fluctuations for
healthy subjects compared to post-stroke subjects (one
example is shown in Fig. 1), leading to slightly reduced
cross-correlation amplitude between BP and BFV for
healthy subjects. However, the difference in the maxi-
mum cross-correlation value Cmax is not significant (see
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Frequency Variable Supine Tilt Hyperventilation CO2 rebreathing Statistics
Range BFV- BFV- BFV- BFV- BFV- BFV- BFV- BFV- BFV- BFV-
MCAR/ MCAL/ MCAR/ MCAL/ MCAR/ MCAL/ MCAR/ MCAL/ MCAR/ MCAL/
Normal Stroke Normal Stroke Normal Stroke Normal Stroke Normal Stroke
side side side side side side side side side side
Low Gain Control 0.94± 0.30 0.97±0.27 1.06±0.21 0.97± 0.21 0.95± 0.41 1.02± 0.43 1.03± 0.15 1.03± 0.15 0.38∗ 0.11∗
Frequency Gain Stroke 0.84± 0.42 0.72±0.37 0.95±0.27 0.95± 0.25 1.09± 0.36 1.08± 0.38 0.92± 0.20 0.95± 0.21 0.48† 0.26†
0.05-0.2Hz Coherence Control 0.65± 0.15 0.59±0.21 0.75±0.08 0.66± 0.19 0.58± 0.18 0.62± 0.19 0.82± 0.09 0.84± 0.08 0.0006∗ 0.0004∗
Coherence Stroke 0.53± 0.19 0.44±0.24 0.70±0.20 0.66± 0.27 0.62± 0.17 0.61± 0.19 0.69± 0.19 0.70± 0.20 0.07† 0.07†
Phase (rad) Control 0.56± 0.27 0.63±0.26 0.62±0.32 0.63± 0.30 0.92± 0.33 0.94± 0.39 0.63± 0.23 0.63± 0.20 0.0002∗ 0.0001∗
Phase (rad) Stroke 0.79± 0.27 0.56±0.38 0.58±0.24 0.60± 0.25 0.86± 0.32 0.94± 0.47 0.42± 0.25 0.49± 0.23 0.74† 0.37†
Heartbeat Gain Control 0.92± 0.18 0.93±0.24 0.91±0.15 0.91± 0.21 0.88± 0.23 0.94± 0.23 0.89± 0.16 0.91± 0.18 0.50∗ 0.73∗
Frequency Gain Stroke 0.77± 0.29 0.82±0.28 0.88±0.27 0.97± 0.43 0.97± 0.24 0.98± 0.28 0.96± 0.28 0.97± 0.31 0.96† 0.84†
0.7-1.4Hz Coherence Control 0.76± 0.15 0.75±0.18 0.75±0.13 0.71± 0.18 0.58± 0.16 0.58± 0.18 0.68± 0.23 0.70± 0.22 0.15∗ 0.27∗
Coherence Stroke 0.64± 0.24 0.63±0.25 0.57±0.23 0.56± 0.21 0.55± 0.20 0.56± 0.21 0.64± 0.25 0.63± 0.27 0.035† 0.05†
Phase (rad) Control 0.32± 0.13 0.27±0.14 0.38±0.18 0.38± 0.20 0.46± 0.27 0.46± 0.26 0.46± 0.26 0.42± 0.24 0.16∗ 0.03∗
Phase (rad) Stroke 0.35± 0.31 0.31±0.24 0.36±0.14 0.36± 0.21 0.47± 0.20 0.49± 0.28 0.42± 0.21 0.42± 0.15 0.95† 0.81†
* P value between physiologic conditions comparisons
† P value between groups comparisons
TABLE II: Gain, coherence and phase in the low frequency (LF, 0.05-0.2 Hz) range and in the heartbeat frequency (HBF,
0.7-1.4 Hz) range for the control and stroke group during different physiologic conditions. We compare data from BFV in the
right MCA (BFV-MCAR) in healthy subjects with data from BFV in the normal side MCA in post-stroke subjects (mean ±
standard deviation values are presented in the left column for each condition). We compare data from BFV in the left MCA
(BFV-MCAL) in healthy subjects with data from BFV in the stroke side MCA in post-stroke subjects (mean ± standard
deviation values are presented in the right column for each condition). The p values from 2x4 MANOVA are calculated for
comparing differences between groups and conditions.
Table III), the reason being that the general shape of
the BP and BFV oscillations at each heartbeat is very
similar for both healthy and post-stroke subjects, and
in addition, the amplitude of BP and BFV oscillations
is much larger relative to the small random fluctuations
on top of these oscillations. In contrast, the shape of
the oscillations observed in the phase increments of the
BP and BFV signals at every heartbeat is very different
for healthy subjects [see Figs. 5(c), 5(d)] but very simi-
lar for post-stroke subjects [see Figs. 5(g), 5(h)]. Thus,
the instantaneous phase cross-correlation between BP
and BFV for healthy subjects is significantly different
from post-stroke subjects, as one can see by comparing
Fig. 2 and Fig. 6. This difference is also shown in Table
III. The comparative statistical tests indicate significant
difference between the control and stroke group based
on the instantaneous phase cross-correlation parameter
Cmax when we compare both the stroke side and the nor-
mal side of post-stroke subjects with healthy subjects.
There is no significant difference in Cmax obtained from
the direct cross-correlation between BP and BFV signals
when we compare the normal side of post-stroke subjects
with healthy subjects (see also results in Sec. III E).
We also note that, healthy subjects exhibit higher vari-
ability in the intervals between consecutive heartbeats,
leading to higher variability in the intervals between con-
secutive peaks in the BP and BFV waves (Fig. 1). As a
result, both the direct cross-correlation and the instanta-
neous phase cross-correlation between the BP and BFV
signals decay faster with increasing the time lag τ for
healthy subjects compared to post-stroke subjects. For
both methods we show that the parameter τ0, which char-
acterizes the decay in the cross-correlations, separates
equally well the stroke group from the control group (see
Table III).
D. Phase Synchronization Analysis
In Fig. 3 we present the results of the phase synchro-
nization analysis for four healthy and four post-stroke
subjects. The statistics for all four physiologic condi-
tions (supine rest, tilt, hyperventilation, CO2 rebreath-
ing) in our database and over the entire control and
stroke groups are summarized in Table III. We find a
statistically significant difference between the control and
stroke group based on the entropy index ρ.
In the phase synchronization method one estimates the
difference between the instantaneous phases of two sig-
nals at the same time. Thus, the phase synchronization
method does not reflect possible time delays between
the two studied signals, and correspondingly, between
their instantaneous phases. Such time delays can often
be observed in coupled physical and physiological sys-
tems [51, 77]. To demonstrate the effect of such time
delay in context of the system we study, we consider the
difference between the instantaneous phases of BP and
BFV, when the phase of BFV is taken at time t1 and the
phase of BP is taken at time t2 = t1 + τ . As we show in
Fig. 4, the result of the phase synchronization analysis is
very different when considering instantaneous phase dif-
ference with a time delay — the histogram of the phase
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FIG. 6: Cross-correlation function C(τ ) of the instantaneous phase increment ∆ϕ for the BP and BFV signals during four
physiologic conditions. We find that the cross-correlation function for all healthy subjects exhibits a very distinct type of
behavior compared to post-stroke subjects. Two typical examples are shown. (Left) A healthy subject: C(τ ) has a small
amplitude at τ = 0 and is close to zero at time lags τ > 5 seconds during all four conditions. (Right) A post-stroke subject:
C(τ ) has a much larger amplitude at τ = 0 which lasts for lags τ up to 20 seconds, indicating a strong coupling between the
BP and BFV signals, i.e., loss of cerebral autoregulation.
difference becomes much broader (the entropy index ρ
much smaller) compared to the case when no time delay
is introduced.
Statistics for the groups and physiologic conditions are
presented in Table III, and indicate a very different result
— no statistically significant difference between the con-
trol and stroke group for the entropy index ρ estimated
for an arbitrary chosen time delay of τ = 0.4 seconds.
This is in contrast to the results obtained for the entropy
index ρ from the synchronization analysis when one does
not consider a time delay. Thus, the results of the tradi-
tional phase synchronization method strongly depend on
the time at which the instantaneous phases of two sig-
nals are compared [51, 77]. This motivates our approach
to investigate the cross-correlation between the instanta-
neous phases of two coupled systems at different time lag
τ , as presented in Sec. III E.
E. Cross-correlation of Instantaneous Phase
Increments
We apply the instantaneous phase increments cross-
correlation analysis to all four conditions and both study
groups. We find that the patterns of the cross-correlation
function C(τ) of the instantaneous phase increments ∆ϕ
of the BP and BFV signals are very different for the
stroke group compared to the control group. In gen-
eral, the cross-correlation function C(τ) for the control
group is characterized by smaller amplitude and faster
decay (time lag τ less than 10 seconds) [Fig. 6]. In
contrast, for post-stroke subjects, the amplitude of the
cross-correlation function C(τ) is much larger and de-
cays much slower (over time lags larger than 10 seconds)
[Fig. 6]. Thus for those post-stroke subjects the changes
of the phase of BFV will change in the approximately
same way with that of BP signals, indicating a strong
synchronization.
The correlations at short time scales (less than 10
seconds) may be partially attributed to the effect of
heart rate (∼1 sec) and respiration (∼5 seconds)— i.e.,
they reflect the effect of other body regulations (simi-
lar to“background noise”) on both BP and BFV signals.
When cerebral autoregulation is effective, because of its
fast-acting mechanism [3], it may also contribute to the
significantly weaker cross-correlations at short time scales
we find in healthy subjects compared to post-stroke sub-
jects (Fig. 6). However, the correlation due to the above
mechanisms will decrease very fast when increasing the
time lag τ between BP and BFV signals. Thus, the cor-
relations at long time scales (>10 seconds) observed for
post-stroke subjects (Fig. 6), cannot be attributed to the
effect of cerebral autoregulation. Instead, the existence
of such strong and sustained cross-correlationsmay imply
that BFV will passively follow the changes of BP, thus in-
dicating absence of vascular dilation or constriction and
impaired cerebral autoregulation for the post-stroke sub-
jects.
To quantitatively distinguish the control group from
the stroke group, we study the characteristics of the cor-
relation function C(τ) for all subjects. For each correla-
tion function C(τ), we first find Cmax, the maximal value
of C(τ), which tells the strength of the correlation. Then
we choose a threshold value, e.g., r = 0.3, search for the
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Variable Supine Tilt Hyperventilation CO2 rebreathing Statistics
BFV- BFV- BFV- BFV- BFV- BFV- BFV- BFV- BFV- BFV-
MCAR/ MCAL/ MCAR/ MCAL/ MCAR/ MCAL/ MCAR/ MCAL/ MCAR/ MCAL/
Normal Stroke Normal Stroke Normal Stroke Normal Stroke Normal Stroke
side side side side side side side side side side
direct cross-correl. Control 0.91± 0.02 0.89± 0.06 0.88± 0.05 0.84± 0.06 0.88± 0.13 0.87± 0.12 0.91± 0.03 0.91 ± 0.03 0.066∗ 0.069∗
Cmax Stroke 0.92± 0.03 0.92± 0.03 0.88± 0.09 0.89± 0.06 0.91± 0.06 0.90± 0.09 0.92± 0.04 0.93 ± 0.04 0.33
† 0.024†
direct cross-correl. Control 6.5± 4.1 6.6± 4.1 3.3± 1.4 3.5± 1.3 3.2± 1.2 3.2± 1.3 4.8± 3.2 5.0± 3.4 0.008∗ 0.01∗
τ0 Stroke 11.4± 6.6 11.2± 6.9 6.5± 5.6 6.4± 5.6 6.2± 5.8 6.2± 5.7 9.8± 7.2 9.6± 7.2 0.0001
† 0.0004†
phase synch. Control 0.32± 0.07 0.31± 0.06 0.25± 0.07 0.23± 0.07 0.21± 0.08 0.20± 0.08 0.27± 0.06 0.26 ± 0.06 < 0.0001∗ 0.0002∗
index ρ for τ = 0 Stroke 0.35± 0.07 0.34± 0.07 0.26± 0.09 0.27± 0.09 0.25± 0.09 0.25± 0.10 0.32± 0.09 0.32 ± 0.09 0.047† 0.008†
phase synch. Control 0.18± 0.05 0.17± 0.05 0.11± 0.05 0.11± 0.06 0.11± 0.06 0.11± 0.06 0.12± 0.05 0.12 ± 0.04 < 0.0001∗ < 0.0001∗
index ρ for τ = 0.4s Stroke 0.21± 0.05 0.21± 0.05 0.11± 0.05 0.12± 0.06 0.11± 0.06 0.11± 0.06 0.13± 0.05 0.13 ± 0.05 0.43† 0.18†
phase cross-correl. Control 0.55±0.17 0.49±0.22 0.39±0.16 0.33± 0.17 0.47± 0.17 0.43± 0.16 0.45± 0.13 0.41 ± 0.13 0.006∗ 0.07∗
Cmax Stroke 0.62± 0.12 0.58±0.14 0.43±0.21 0.47± 0.20 0.51± 0.19 0.52± 0.20 0.57± 0.20 0.58 ± 0.21 0.049
† 0.001†
phase cross-correl. Control 2.0± 2.0 2.0± 1.7 2.2± 1.3 2.5± 1.5 2.0± 0.9 2.0± 0.9 2.6± 1.5 2.6± 1.5 0.6∗ 0.7∗
τ0 Stroke 6.6± 6.7 5.9± 5.3 3.8± 3.4 3.6± 3.5 5.3± 5.6 5.7± 5.9 5.9± 5.4 5.8± 5.6 0.0003
† 0.0004†
* P value between physiologic conditions comparisons
† P value between groups comparisons
TABLE III: The maximum correlation strength Cmax and the characteristic lag τ0 obtained from the direct cross-correlation
of the BP and BFV signals and from the cross-correlation of the instantaneous phase increments in the BP and BFV signals,
as well as the entropy index ρ obtained from the synchronization analysis for the control and stroke group during different
physiologic conditions. We compare data from BFV in the right MCA (BFV-MCAR) in healthy subjects with data from BFV
in the normal side MCA in post-stroke subjects (mean ± standard deviation values are presented in the left column for each
condition). We compare data from BFV in the left MCA (BFV-MCAL) in healthy subjects with data from BFV in the stroke
side MCA in post-stroke subjects (mean ± standard deviation values are presented in the right column for each condition).
The p values from 2x4 MANOVA are calculated for comparing groups and conditions difference.
maximum of |C(τ)| during each heart beat period along
both positive and negative lags, and find two points in
those maxima with largest time lags at which the cor-
relation are still above rCmax. The average of absolute
values of these two points gives the characteristic time
lags τ0. From τ0 and Cmax for all subjects and during all
physiologic conditions, one can confirm that the stroke
group tends to have larger Cmax and longer time lag τ0
compared to those for the control group.
We apply MANOVA to demonstrate whether τ0 and
Cmax are different for healthy and post-stroke subjects.
The results are shown in Table III. We find that during
tilt and hyperventilation, the control and stroke groups
are not significantly different (p values > 0.05). In con-
trast, during supine rest and CO2 re-breathing, the dif-
ference between the control group and the stroke group
becomes significant (p values < 0.05).
To explain the above difference in τ0 and Cmax dur-
ing supine rest, we note that post-stroke subjects ex-
hibit higher BP and CO2 mean values in baseline (see
Table I). Therefore, the BP-BFV autoregulatory curve
for post-stroke subjects is shifted to the right, to higher
BP values, while at the same time the plateau of this
curve is narrowed due to the higher level of CO2 [3]. CO2
rebreathing increases the level of the CO2 after the pe-
riod of hyperventilation (hypocapnia), thus further test-
ing the reactivity of the CA which shows impaired vasodi-
latatory responses in post-stroke subjects. In contrast,
vasoconstrictor responses to tilt-up hyperventilation are
preserved.
IV. DISCUSSION AND CONCLUSIONS
In this study we investigate dynamics of cerebral au-
toregulation from the relationship between the periph-
eral BP in the finger and the cerebral BFV for a group of
healthy and post-stroke subjects during the four different
physiologic conditions of supine, tilt, hyperventilation,
CO2 rebreathing. The mechanism of cerebral autoregula-
tion is traditionally accessed through the response of the
average cerebral BFV to abrupt perturbation in the the
average BP (e.g., upright tilt from supine position), and
is typically characterized by the ability of the cerebral
blood vessels to restore equilibrium and a steady cerebral
blood flow after such perturbation — a process which is
known to operate on time scales above several heartbeats.
In contrast, we focus on the dynamical characteristics of
the pressure-flow fluctuation around average values. We
show that in healthy subjects the CA mechanism is ac-
tive even during the steady equilibrium state. Moreover,
we find that on top of the BFV waveforms associated
each heartbeat there are robust fluctuations which are
reduced in the post-stroke subjects, indicating an active
cerebral vascular regulation in healthy subjects on time
scales within a single heartbeat even under steady BP.
To test for the dynamical patterns in the BP-BFV
fluctuations we use four different methods, and we com-
pare the results of the analyses by evaluating the com-
bined effects of pressure autoregulation (upright tilt) and
metabolic autoregulation (hyperventilation and CO2 re-
breathing) in healthy and post-stroke subjects. We find
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that the gain and phase obtained from the traditional
transfer function analysis do not provide a significant
difference between healthy and post-stroke subjects. In
contrast, the coherence is significantly different in the
heartbeat frequency range (0.7-1.4 Hz) when we compare
both the normal side and the stroke side of post-stroke
subjects with healthy subjects.
Further, we find that the amplitude of the direct cross-
correlation between the BP and BFV signals does not
separate the control from the stroke group and between
different physiologic conditions when we compare the
normal side of post-stroke subjects with healthy subjects.
However, comparing the stroke side of post-stroke sub-
jects with healthy subjects, we find a statistically signif-
icant difference, suggesting that direct cross-correlation
method is sensitive to detect abnormalities in CA only
for the stroke side. In addition, we observe a significantly
faster decay in the BP-BFV cross-correlation function for
healthy subjects, reflecting higher beat-to-beat variabil-
ity in the BP and BFV signals, compared to post-stroke
subjects.
Since both BP and BFV are driven by the heartbeat,
we also test the coupling between these two signals ap-
plying the phase synchronization method. For healthy
subjects we observe a weaker synchronization between
BP and BFV characterized by lower value of the syn-
chronization index ρ compared to post-stroke subjects,
indicating that the CA mechanism modulates the cere-
bral BFV waves so that they are not completely synchro-
nized with peripheral BP waves driven by the heartbeat.
We find a significantly stronger BP-BFV synchronization
in post-stroke subjects associated with loss of cerebral
autoregulation.
To probe how the CA mechanism modulates the BFV
we investigate the dynamical patterns in the instanta-
neous phase increments of the BP signals ∆ϕBP and
compare them with the patterns we find in the instan-
taneous phase increments of the BFV signals ∆ϕBFV .
Remarkably, we find that for post-stroke subjects ∆ϕBP
and ∆ϕBFV exhibit practically identical patterns in time,
leading to very high degree of cross-correlation between
∆ϕBP and ∆ϕBFV . In contrast, for healthy subjects
∆ϕBFV exhibits robust random fluctuations very dif-
ferent from the structured oscillatory patterns we find
in ∆ϕBP . This leads to a significantly reduced cross-
correlation between ∆ϕBP and ∆ϕBFV for healthy sub-
jects compared to post-stroke subjects. Our results in-
dicate a statistically significant separation between the
stroke and the control group when we compare both the
normal and the stroke side in post-stroke subjects with
healthy subjects. This suggests that our new approach
based on cross-correlation of the instantaneous phase in-
crements of BP and BFV is sensitive to detect impair-
ment of cerebral vascular autoregulation in both hemi-
spheres for subjects with minor ischemic stroke.
Our findings of robust fluctuations in ∆ϕBFV , which
do not synchronize with periodic patterns in ∆ϕBP ,
clearly indicate that the mechanism of cerebral autoreg-
ulation impacts the dynamics not only on scales above
several heartbeats but is also active within a single heart-
beat, i.e., much shorter time scales than previous known.
Since these fluctuations are present in the data after we
have truncated the a part of BP and BFV signals cor-
responding to the initial perturbation related to changes
in the physiologic condition, our results also suggest that
the cerebral autoregulation plays an important role even
in the quasi-steady state.
Acknowledgments
Z.C., K.H., H.E.S., and P.Ch.I. acknowledge sup-
port from NIH Grant No. HL071972, No. 2RO1
HL071972 and NIH/National Center for Research Re-
sources Grant No. P41RR13622. V.N. acknowledges
support from CIMIT - New Concept grant (W81XWH),
American Heart Foundation Grant No. 99 30119N, 1R01
NIH-NINDS (1R01-NS045745-01), NIH GCRC Grant 5
MOIRR00034 and MO1-RR01302, and The Older Amer-
ican Independence Center Grant 2P60 AG08812-11.
[1] N. A. Lassen, Physiol. Rev. 39, 183 (1959).
[2] K. Narayanan, J. J. Collins, J. Hamner, S. Mukai, and
L.A. Lipsitz, Am. J. Physiol. Regulatory Integrative
Comp. Physiol. 281, R716 (2001).
[3] R. B. Panerai, Physiol. Meas. 19, 305 (1998).
[4] S. Schwarz, D. Georgiadis, A. Aschoff, and S. Schwab,
Stroke 33, 497 (2002).
[5] P. J. Eames, M. J. Blake, S. L. Dawson, R. B. Panerai,
and J. F. Potter, J. Neurol. Neurosur. Ps. 72, 467 (2002).
[6] V. Novak, A. Chowdhary, B. Farrar, H. Nagaraja, J.
Braun, R. Kanard, P. Novak, and A. Slivka, Neurology
60, 1657 (2003).
[7] V. Novak, A. C. Yang, L. Lepicovsky, A. L. Goldberger,
L. A. Lipsitz, and C.-K. Peng, BioMedical Engineering
online 3, 39 (2004).
[8] S. S. Kety, and C. F. Schmidt, J. Clin. Invest. 29, 476
(1948).
[9] W. D. Obrist, H. K. Thompson, H. S. Wang, and W. E.
Wilkinson, Stroke 6, 245 (1975).
[10] R. Aaslid, K. F. Lindegaard, W. Sorteberg, and H.
Nornes, Stroke 20, 45 (1989).
[11] F. P. Tiecks, A. M. Lam, R. Aaslid, and D. W. Newell,
Stroke 26, 1014 (1995).
[12] S. L. Dawson, M. J. Blake, R. B. Panerai, and J. F.
Potter, Cerebrovasc. Dis. 10, 126 (2000).
[13] R. B. Panerai, S. L. Dawson, and J. F. Potter, Am. J.
Physiol. Heart Circ. Physiol. 277, H1089 (1999).
[14] R. B. Panerai, S. L. Dawson, P. J. Eames, and J. F.
Potter, Am. J. Physiol. Heart Circ. Physiol. 280, H2162
(2001).
14
[15] P. Ch. Ivanov, M. G. Rosenblum, C.-K. Peng, J. Mietus,
S. Havlin, H. E. Stanley, and A. L. Goldberger, Nature
383, 6598 (1996).
[16] S. Havlin, L. A. N. Amaral, Y. Ashkenazy, A. L. Gold-
berger, P. Ch. Ivanov, C.-K. Peng, and H. E. Stanley,
Physica A 274, 99 (1999).
[17] P. Ch. Ivanov, L. A. N. Amaral, A. L. Goldberger, S.
Havlin, M. G. Rosenblum, H. E. Stanley, and Z. R.
Struzik, Chaos 11, 641 (2001).
[18] A. L. Goldberger, L. A. N. Amaral, J. M. Hausdorff,
P. Ch. Ivanov, C.-K. Peng, and H. E. Stanley, Proc. Natl.
Acad. Sci. U.S.A. 99, 2466 (2001).
[19] P. Bernaola-Galvan, P. Ch. Ivanov, L. A. N. Amaral, and
H. E. Stanley, Phys. Rev. Lett. 87, 168105 (2001).
[20] M. Meyer, and O. Stiedl, Euro. J. Appl. Physiol. 90, 305
(2003).
[21] P. Ch. Ivanov, Z. Chen, K. Hu, and H. E. Stanley, Phys-
ica A 344, 685 (2004).
[22] A. N. Pavlov, A. R. Ziganshin, and O. A. Klimova, Chaos
Solitons Fract 24, 57 (2005).
[23] B. Suki, A. L. Barabasi, Z. Hantos, F. Petak, and H. E.
Stanley, Nature 368, 615 (1994).
[24] A. M. Alencar, S. V. Buldyrev, A. Majumdar, H. E. Stan-
ley, and Suki, Phys. Rev. Lett. 87, 088101 (2001).
[25] B. Suki, A. M. Alencar, U. Frey, P. Ch. Ivanov, S. V.
Buldyrev, A. Majumdar, H. E. Stanley, C. A. Dawson,
G. S. Krenz, and M. Mishima, Fluc. Noise Lett. 3, R1
(2003).
[26] W. A. C. Mutch, M. R. Graham, L. G. Girling, and J. F.
Brewster, Resp. Res. 6, 41 (2005).
[27] B. J. West, L. A. Griffin, H. J. Frederick, and R. E. Moon,
Resp. Physiol. Neurobi. 145, 219 (2005).
[28] J. M. Hausdorff, P. L. Purdon, C.-K. Peng, Z. Ladin,
J. Y. Wei, and A. L. Goldberger, J. Appl. Physiol. 80,
1448 (1996).
[29] J. M. Hausdorff, Y. Ashkenazy, C.-K. Peng, P. Ch.
Ivanov, H. E. Stanley, and A. L. Goldberger, Physica
A 302, 138 (2001).
[30] Y. Ashkenazy, J. A. Hausdorff, P. Ch. Ivanov, and H. E.
Stanley, Physica A 316, 662 (2002).
[31] N. Scafetta, L. Griffin, B. J. West, Physica A 328, 561
(2003).
[32] K. Hu, P. Ch. Ivanov, Z. Chen, M. F. Hilton, H. E. Stan-
ley, and S. A. Shea, Physica A 337, 307 (2004).
[33] P. Ch. Ivanov, J. M. Hausdorff, S. Havlin, L. A. N. Ama-
ral, K. Arai, V. Schulte-Frohlinde, M. Yoneyama, and H.
E. Stanley, arXiv:cond-mat/0409545 (2004).
[34] B. J. West, M. Latka, M. Glaubic-Latka, and D. Latka,
Physica A 318, 453 (2003).
[35] I. H. Song, and D. S. Lee, Lect. Notes. Comput. Sc. 3561,
195 (2005).
[36] M. Bachmann, J. Kalda, J. Lass, V. Tuulik, M. Sakki,
and H. Hinrikus, Med. Biol. Eng. Comput. 43, 142
(2005).
[37] R. Karasik, N. Sapir, Y. Ashkenazy, P. Ch. Ivanov, I.
Dvir, P. Lavie, and S. Havlin, Phys. Rev. E 66, 062902
(2002).
[38] M. Martinis, A. Knezevic, G. Krstacic, and E. Vargovic,
Phys. Rev. E 70, 012903 (2004).
[39] P. Ch. Ivanov, A. Bunde, L. A. N. Amaral, S. Havlin, J.
Fritsch-Yelle, R. M. Baevsky, H. E. Stanley, and A. L.
Goldberger, Europhys. Lett. 48, 594 (1999).
[40] A. Bunde, S. Havlin, J. W. Kantelhardt, T. Penzel, J. H.
Peter, and K. Voigt, Phys. Rev. Lett. 85, 3736 (2000).
[41] J. W. Kantelhardt, Y. Ashkenazy, P. Ch. Ivanov, A.
Bunde, S. Havlin, T. Penzel, J. H. Peter, and H. E. Stan-
ley, Phys. Rev. E 65, 051908 (2002).
[42] A. Dudkowska and D. Makowiec, Physica A 336, 174
(2004).
[43] M. Staudacher, S. Telser, A. Amann, H. Hinterhuber,
and M. Ritsch-Marte, Physica A 349, 582 (2005).
[44] K. Hu, P. Ch. Ivanov, M. F. Hilton, Z. Chen, R. T. Ayers,
H. E. Stanley, and S. A. Shea, Proc. Natl. Acad. Sci.
U.S.A. 101, 18223 (2004).
[45] C. Hugenii, Horoloquim Oscilatorium (Parisiis, France,
1673).
[46] V. S. Anischenko, T. E. Vadivasova, D. E. Postnov, and
M. A. Safonova, Int. J. Bifurcation Chaos Appl. Sci. Eng.
2, 633 (1992).
[47] L. Fabiny, P. Colet, R. Roy, and D. Lenstra, Phys. Rev.
A 47, 4287 (1993); R. Roy, and K. S. Thornburg, Phys.
Rev. Lett. 72, 2009 (1994).
[48] J. F. Heagy, T. L. Carroll, and L. M. Pecora, Phys. Rev.
E 50, 1874 (1994).
[49] I. Schreiber, and M. Marek, Physica (Amsterdam) 5D,
258 (1982); S. K. Han, C. Kurrer, and Y. Kuramoto,
Phys. Rev. Lett. 75, 3190 (1995).
[50] S. Bahar, A. Neiman, L. A. Wilkens, and F. Moss, Phys.
Rev. E 65, 050901 (R) (2002).
[51] D. Rybski, S. Havlin, and A. Bunde, Physica A 320, 601
(2003).
[52] S. Bahar and F. Moss, Chaos 13, 138 (2003).
[53] A. S. Pikovsky. Radiophys. Quantum Electron. 27, 576
(1984).
[54] Y. Kuznetsov, P. Landa, A. Ol’khovoi, and S. Perminov,
Sov. Phys. Dokl. 30, 221 (1985).
[55] M. G. Rosenblum, A. S. Pikovsky, and J. Kurths, Phys.
Rev. Lett. 76, 1804 (1996).
[56] M. G. Rosenblum, A. S. Pikovsky, and J. Kurths, Phys.
Rev. Lett. 78, 4193 (1997).
[57] U. Parlitz, L. Junge, W. Lauterborn, and L. Kocarev,
Phys. Rev. E 54, 2115 (1996).
[58] S. Bahar, Fluc. Noise Lett. 4, L87 (2004).
[59] A. S. Pikovsky, M. G. Rosenblum, and J. Kurths, Syn-
chronization: A Universal Concept in Nonlinear Sciences
(Cambridge University Press, Cambridge, 2001).
[60] S. Boccaletti, J. Kurths, G. Osipov, D. L. Valladares,
and C. S. Zhou, Phys. Rep. 366, 1 (2002).
[61] C. Schafer, M. G. Rosenblum, J. Kurths, H. H. Abel,
Nature (London) 392, 239 (1998).
[62] K. Kotani, I. Hidaka, Y. Yamamoto, and S. Ozono,
Method. Inform. Med. 39, 153 (2000).
[63] M. B. Lotric and A. Stefanovska, Physica A 283, 451
(2000).
[64] R. Mrowka, A. Patzak, M. G. Rosenblum, Int. J. Bifurc.
Chaos 10, 2479 (2000).
[65] A. Stefanovska, H. Haken, P. V. E. McClintock, M. Hozic,
F. Bajrovic, and S. Ribaric, Phys. Rev. Lett. 85, 4831
(2000).
[66] A. Stefanovska and M. Hozic, Prog. Theor. Phys. Suppl.
139, 270 (2000).
[67] L. Angelini, M. D. Tommaso, M. Guido, K. Hu, P. Ch.
Ivanov, D. Marinazzo, G. Nardulli, L. Nitti, M. Pellicoro,
C. Pierro, and S. Stramaglia, Phys. Rev. Lett. 93, 038103
(2004).
[68] P. Tass, M. G. Rosenblum, J. Weule, J. Kurths, A.
Pikovsky, J. Volkmann, A. Schnitzler and H.-J. Freund,
Phys. Rev. Lett. 81, 3291 (1998).
15
[69] F. Nobili, G. Rodriguez, A. Arrigo, B. M. Stubinski, E.
Rossi, and R. Cerri et al., Lupus 5, 93 (1996).
[70] G. Leftheriotis, J. M. Geraud, M. P. Preckel, and J. L.
Saumet, Clin. Physiol. 15, 537 (1995).
[71] H. Sugimori, S. Ibayashi, K. Fujii, S. Sadoshima, Y.
Kuwabara Y, and M. Fujishima, Stroke 26, 2053 (1995).
[72] J. M. Serrador, P. A. Picot, B. K. Rutt, J. K. Shoemaker,
and R. L. Bondar, Stroke 31, 1672 (2000).
[73] J. F. Claerbout, Fundamentals of Geophysical Data Pro-
cessing ( McGraw-Hill, New York, 1976).
[74] A. V. Oppenheim, and R. W. Schafer, Discrete-Time
signal Processing, 2nd ed. (Prentice-Hall, UpperSaddle
River, New Jersey, 1998).
[75] P. Ch. Ivanov, A. L. Goldberger, S. Havlin, C.-K Peng,
M. G. Rosenblum, and H. E. Stanley, “Wavelets in
Medicine and Physiology” in “Wavelets in Physics”, ed-
itor J. C. van den Berg (Cambridge University Press,
Cambridge, 1998).
[76] S. L. Marple, IEEE T. Signal Proces. 47, 2600 (1999).
[77] L. Cimponeriu, M. Rosenblum, and A. Pikovsky, Phys.
Rev. E 70, 046213 (2004).
